Global Medical REIT Inc. Amends and Restates Credit Facility
MWN-AI** Summary
Global Medical REIT Inc. (NYSE: GMRE) has successfully amended and restated its credit facility, significantly altering the structure and maturity of its debt obligations. This strategic move extends the maturities of its existing borrowings, which is a pivotal step in enhancing the financial stability of the company. Specifically, the initial maturity date of the $400 million revolver component has been extended to October 2029, with options to further extend into 2030. Additionally, the $350 million Term Loan A has been restructured into three separate tranches, maturing in October 2029, October 2030, and April 2031.
A noteworthy alteration is the removal of the previous 0.10% secured overnight financing rate (SOFR) credit spread adjustment on all borrowings. The overall debt maturity profile of the company has improved, with the weighted average term of its debt rising from 1.3 years to 4.4 years following this amendment.
To mitigate the risks associated with fluctuating interest rates, GMRE has also entered into $350 million of forward starting interest rate swaps that will hedge the SOFR component of the new Term Loan A tranches. The fixed rates on these swaps range from 3.24% to 3.32%, resulting in effective interest rates between 4.75% and 4.84%.
The underwriting of this amended credit facility was spearheaded by a consortium that included prominent financial institutions such as JPMorgan Chase Bank, BMO Capital Markets, and Wells Fargo Securities. This revamping of the credit facility positions Global Medical REIT for continued growth and operational efficiency in leasing healthcare facilities, thereby reinforcing its commitment to expanding its investment in the medical real estate sector. More information about GMRE can be found on its website.
MWN-AI** Analysis
Global Medical REIT Inc. (NYSE: GMRE) recently announced significant amendments to its credit facility, a strategic move that has implications for its financial stability and growth potential. The company's proactive extension of loan maturities from an average of 1.3 years to 4.4 years enhances liquidity and allows for more predictable cash flow management.
Notably, the restructuring includes a $400 million revolver due in October 2029, with options to extend that maturity, alongside a revised three-part Term Loan A totaling $350 million, maturing between 2029 and 2031. This extended timeline lessens refinancing pressure in a potentially volatile interest rate environment, which is particularly favorable in the current macroeconomic landscape.
The removal of the 0.10% SOFR credit spread adjustment is an added benefit, reducing borrowing costs in relation to the prevailing market rates. Furthermore, GMRE's decision to engage in $350 million of forward starting interest rate swaps mitigates risks associated with interest rate fluctuations, securing fixed rates across term loans effectively ranging from 4.75% to 4.84%. Given the prevailing interest rate trends, this hedging strategy positions the company favorably against potential rate increases.
For investors, GMRE’s actions signal a robust commitment to financial prudence, suggesting confidence in generating sufficient revenue from its net-lease healthcare facility portfolio. As occupancy rates in healthcare sectors remain resilient, this could lead to improved cash flows and dividend sustainability.
However, it is vital for investors to remain cautious. Global uncertainties, changing healthcare regulations, and potential disruptions in leasing demand could impact performance. Monitoring GMRE's operational metrics and market conditions will be crucial. Currently, GMRE appears well-prepared for the future, making it a potential buy for risk-tolerant investors interested in the healthcare real estate sector.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
– Extends Loan Maturities and Enters into Forward Starting Interest Rate Swaps to Hedge Term Loans –
– Weighted Average Term of the Company’s Debt Increases from 1.3 Years to 4.4 Years –
Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that it entered into an amended and restated credit facility (the “Amended and Restated Credit Facility”) that extends the maturities of its borrowings and, among other things, includes the following terms:
- Extends the initial maturity date of the existing $400 million revolver component of the credit facility to October 2029 with two, six-month extension options available at the Company’s election to extend the maturity to October 2030; and
- Extends the maturity of the existing $350 million Term Loan A, dividing it into three term loans structured as follows:
- $100 million term loan maturing in October 2029 (“Term Loan A-1”);
- $100 million term loan maturing in October 2030 (“Term Loan A-2”); and
- $150 million term loan maturing in April 2031 (“Term Loan A-3”); and
- Removes the previous 0.10% (10 basis point) secured overnight financing rate (“SOFR”) credit spread adjustment on all credit facility borrowings.
The credit facility’s pricing grid, $150 million Term Loan B that matures in February 2028, and $500 million accordion remain unchanged.
In connection with the Amended and Restated Credit Facility, the Company entered into $350 million of forward starting interest rate swaps to fully hedge the SOFR component of the three Term Loan A tranches through their respective maturities as follows:
Term Loan A Tranches | Interest Rate Swap Term | Fixed Base Rate | Effective | |||
$100 million Term Loan A-1 | May 2026 through October 2029 | 3.24% | 4.75% | |||
$100 million Term Loan A-2 | May 2026 through October 2030 | 3.28% | 4.80% | |||
$150 million Term Loan A-3 | May 2026 through April 2031 | 3.32% | 4.84% | |||
(1) Rates consist of the fixed SOFR base rate plus a borrowing spread of 1.45% based on a leverage ratio of between 45% and 50% and is calculated using 365/360 method. |
The existing $350 million Term Loan A fixed rate SOFR swaps remain in place, resulting in an all-in fixed interest rate of 2.85% on this debt through the swap maturities in April 2026.
At closing of the Amended and Restated Credit Facility, the weighted average term of the Company’s debt, including the drawn revolver component, was 4.4 years.
The Joint Lead Arrangers and Joint Book Runners for the facility were JPMorgan Chase Bank, N.A., BMO Capital Markets Corp., Wells Fargo Securities, LLC, Citizens Bank, N.A., Huntington National Bank and Truist Securities, Inc. JPMorgan Chase Bank, N.A. serves as Administrative Agent, BMO Capital Markets Corp. and Wells Fargo Bank, N.A. serve as Syndication Agents, Citizens Bank, N.A., Huntington National Bank and Truist Bank serve as Documentation Agents. Associated Bank, National Association, Raymond James Bank, N.A., and Stifel Bank & Trust also participated in the credit facility.
About Global Medical REIT Inc.
Global Medical REIT Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. Additional information on GMRE can be obtained on its website at www.globalmedicalreit.com.
Forward-Looking Statements
Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company’s intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "plan," "predict," "project," "will," "continue" and other similar terms and phrases, including references to assumptions and forecasts of future results. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company’s forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251008895076/en/
Investor Relations:
Email: Investors@globalmedicalreit.com
Phone: 202.524.6869
FAQ**
How does the extension of maturities for Global Medical REIT Inc. (GMRE) influence its long-term financial stability and growth potential in the medical real estate sector?
What impact will the newly entered interest rate swaps have on Global Medical REIT Inc. (GMRE)'s financial obligations and overall interest expense management moving forward?
How does the new credit facility position Global Medical REIT Inc. (GMRE) in comparison to its competitors in the net-lease medical REIT market?
What are the anticipated risks associated with the forward-looking statements made by Global Medical REIT Inc. (GMRE) in light of the current economic conditions?
**MWN-AI FAQ is based on asking OpenAI questions about Global Medical REIT Inc. (NYSE: GMRE).
NASDAQ: GMRE
GMRE Trading
0.31% G/L:
$35.81 Last:
30,335 Volume:
$36.20 Open:
